D R Jasinski, W R Martin, R Hoeldtke. Show Affiliations »
Abstract
Entities: Chemical Species
Mesh: See more » Analgesics/pharmacologyAnalgesics/therapeutic useBridged-Ring Compounds/therapeutic useDextropropoxyphene/therapeutic useHumansInjections, IntramuscularInjections, IntravenousInjections, SubcutaneousMorphinans/therapeutic useMorphine/administration & dosageMorphine/antagonists & inhibitorsMorphine Dependence/drug therapyNalorphine/pharmacologyPentazocine/therapeutic usePhenols/therapeutic usePiperidines/therapeutic usePlacebosPupil/drug effectsPyridines/therapeutic usePyrrolidines/therapeutic useReceptors, DrugSubstance Withdrawal SyndromeSubstance-Related DisordersSurveys and QuestionnairesTime Factors
Substances: See more » AnalgesicsBridged-Ring CompoundsMorphinansPhenolsPiperidinesPlacebosPyridinesPyrrolidinesReceptors, DrugMorphinePentazocineDextropropoxypheneNalorphine
Year: 1971 PMID: 5567808 DOI: 10.1002/cpt1971124613
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN: 0009-9236 Impact factor: 6.875